TPD & Induced Proximity Summit Leaderboard
  • Friday, July 10, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 432

Author

Pharma Journalist 8922 posts 0 comments

Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and…

Nov 30, 2020
Telix Pharmaceuticals Limited announces it has entered into an agreement with Scintec Diagnostics GmbH (‘Scintec’) to acquire TheraPharm GmbH (‘TheraPharm’), a Swiss-German…
Read More...

Cedilla and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug…

Nov 30, 2020
Shanghai Stock Exchange listed company HitGen Inc. announced that it has entered into a research collaboration agreement with Cedilla Therapeutics, Inc. a private biotechnology company…
Read More...

Astellas Receives Approval of EVRENZO (roxadustat) in Japan for the Treatment of Anemia of Chronic…

Nov 27, 2020
FibroGen, Inc. and Astellas Pharma Inc.  announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved EVRENZO (roxadustat) for the treatment of anemia of chronic kidney…
Read More...

Haoma Medica Completes First-in-Human Trial for NaQuinate, a Novel Treatment in Development for…

Nov 27, 2020
Haoma Medica announced the completion of a first-in-human trial for NaQuinate, a naphthoquinone carboxylic acid, which is being developed as a novel orally administered therapeutic for…
Read More...

EMA Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping…

Nov 27, 2020
Merck announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung…
Read More...

Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential…

Nov 27, 2020
Biogen Inc. and Sage Therapeutics, Inc. announced that they have executed a global collaboration and license agreement to jointly develop and commercialize zuranolone (SAGE-217) for…
Read More...

BioInvent and Cantargia sign manufacturing agreement for monoclonal antibody CAN10

Nov 26, 2020
Cantargia AB and BioInvent International AB announced that BioInvent has been contracted as manufacturer of Cantargia's antibody CAN10 in preclinical development for the treatment of…
Read More...

FDA Defers Approval of DaxibotulinumtoxinA for Injection in Glabellar Lines Due to COVID-19 Related…

Nov 26, 2020
Revance Therapeutics, Inc. a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the United States (U.S.) Food and Drug Administration…
Read More...

Celltrion completes enrolment for global Phase II clinical trial with COVID-19 treatment candidate…

Nov 26, 2020
Celltrion Group announced enrolment completion of 327 patients with mild-to-moderate symptoms of SARS-CoV-2 infection in the global Phase II clinical trial of CT-P59, an anti-COVID-19…
Read More...

Chairs post an invitation letter for the 15th Annual Parallel Trade conference 2021

Nov 26, 2020
SMi Reports: Invitation letter released from the chair of the Parallel Trade virtual conference taking place in March 2021. SMi Group is delighted to present the 15th annual…
Read More...
Prev Next
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Evogene, Tel Aviv University Launch AI Drug Discovery Initiative
  • Wainua Misses Primary Endpoint in ATTR-CM Phase III Trial
  • Cyllene Raises €33m to Advance Neurogenic Bladder DNA Medicine
  • Biocytogen and Whitehawk Partner on Bispecific ADC Development
  • FDA Grants Rare Pediatric Disease Status to Vanda’s CMT2S Therapy

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.